Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Manfredi Ponente"'
Supplementary Figure 3: EZN-2208 affects leukemic stromal cell numbers.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0bcf07d7baf31dd2cc976a85a21db500
https://doi.org/10.1158/1078-0432.22457192.v1
https://doi.org/10.1158/1078-0432.22457192.v1
Supplementary Figure 4: Combined effect of EZN-2208 and ATRA on NB4 cell viability and differentiation.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09777fe46fdd8be498c48a47c4e399f0
https://doi.org/10.1158/1078-0432.22457189
https://doi.org/10.1158/1078-0432.22457189
Supplementary Figure 1: EZN-2208 does not impair cell migration and colony formation in U937-MT control cells
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c62c55461fa457c6c7fabfb9737f25cc
https://doi.org/10.1158/1078-0432.22457198.v1
https://doi.org/10.1158/1078-0432.22457198.v1
Supplementary Figure 2: High doses EZN-2208 induce apoptosis in leukemic bone marrow cells.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::822a5c55a5aa660f3345707c694ba571
https://doi.org/10.1158/1078-0432.22457195.v1
https://doi.org/10.1158/1078-0432.22457195.v1
Purpose: Retinoic acid-arsenic trioxide (ATRA-ATO) combination therapy is the current standard of care for patients with acute promyelocytic leukemia (APL) carrying the oncogenic fusion protein PML-RARα. Despite the high cure rates obtained with thi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a880407d85e18676f81aaeede2ff5b3f
https://doi.org/10.1158/1078-0432.c.6523532
https://doi.org/10.1158/1078-0432.c.6523532
Autor:
Giacomo A. Delledonne, Linda Pattini, Roberto Cuttano, Claudio Doglioni, Letizia Campanini, Ugo Cavallaro, Nadia Coltella, Manfredi Ponente, Alessandra Villa, Rosa Bernardi, Roberta Valsecchi, Andrea Piunti
Publikováno v:
JCI Insight
Elucidating the molecular basis of tumor metastasis is pivotal for eradicating cancer-related mortality. Triple-negative breast cancer (TNBC) encompasses a class of aggressive tumors characterized by high rates of recurrence and metastasis, as well a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::87638df7b251ac68e547defd7f686aeb
https://europepmc.org/articles/PMC5313064/
https://europepmc.org/articles/PMC5313064/
Autor:
Maria Teresa Sabrina Bertilaccio, Federico Caligaris-Cappio, Manfredi Ponente, Paola Brambilla, Giovanni Tonon, Rosa Bernardi, Elisabetta Ferrero, Filippo Martinelli Boneschi, Paolo Ghia, Maurilio Ponzoni, Marina Ferrarini, Andrea Brendolan, Elisa Lenti, Elisa Ten Hacken, Lydia Scarfò, Cristina Scielzo, Daniela Belloni, Roberta Valsecchi, Nadia Coltella
Hypoxia-inducible transcription factors (HIFs) regulate a wide array of adaptive responses to hypoxia and are often activated in solid tumors and hematologic malignancies due to intratumoral hypoxia and emerging new layers of regulation. We found tha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::897a46a38b28cf0c0813a283e31eccfd
http://www.bloodjournal.org/content/bloodjournal/127/16/1987.full.pdf
http://www.bloodjournal.org/content/bloodjournal/127/16/1987.full.pdf
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 21(16)
Purpose: Retinoic acid-arsenic trioxide (ATRA-ATO) combination therapy is the current standard of care for patients with acute promyelocytic leukemia (APL) carrying the oncogenic fusion protein PML-RARα. Despite the high cure rates obtained with thi